Engineering Resilience: Mastering Pharma Patent...

By Rene Pretorius

April 2, 2025

The recent decision by Novartis to lay off 427 employees in New Jersey highlights a persistent challenge in the pharmaceutical industry: the looming threat of
Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefit...
Journavx Market Access Strategy in Focus: What Early Payer Decisions Signal f...
Pharmacy Benefit Managers Report Reveals Escalating Drug Costs and Calls for ...
Reevaluating NICE’s Cost-Effectiveness Thresholds: The QALY Debate
Access to Anti-Obesity Medication for Medicare and Medicaid
Sanofi’s 340B Rebate Model: A Joint Effort to Reform Drug Pricing Pract...
NICE Rejects Donanemab for NHS Use Due to Cost Concerns
Innovative Pricing and Payment Models for Health Technologies
UNAIDS Urges Greater Access for Gilead’s Lenacapavir
Soaring Drug Prices in Europe: A Strain on Health Systems and Industry
The Readiness of Biosimilars in Multiple Sclerosis Treatment
Alzheimer’s Treatments: Evaluating Emerging Therapies and NICE’s ...